This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Advances in the elucidation of the etiopathogenesis of myasthenia gravis have come rapidly in the past half decade. The advent of therapeutic plasmapheresis stands out as a practical, clinical outgrowth of this enhanced understanding of the immunobiology of myasthenia. This new therapeutic modality and the immunologic studies leading to its inception have captured the fancy of both clinicians and investigators, so it is appropriate that knowledge of the state of the art be made available to as wide an audience as possible. That task has been effectively accomplished in this volume, which contains a series of papers presented at an international symposium on plasmapharesis and the immunobiology of myasthenia held in San Francisco, June 1978.
The book is divided into five parts, the first of which consists of ten papers dealing with the immunobiology of the acetylcholine receptor. Part 2 deals with thymectomy and thoracic duct drainage, their indications and
Rodnitzky RL. Plasmapheresis and the Immunobiology of Myasthenia Gravis. Arch Neurol. 1979;36(9):600. doi:10.1001/archneur.1979.00500450094030
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: